Polarityte
WebJan 20, 2024 · PolarityTE, Inc. Common Stock (PTE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebDec 13, 2016 · PolarityTE is focused on transforming the lives of patients by discovering, designing & developing regenerative tissue products & biomaterials. polarityte.com Joined December 2016 2,315 Following …
Polarityte
Did you know?
WebApr 13, 2024 · PolarityTE currently has a consensus target price of $1.00, indicating a potential upside of 163.99%. Vaxart has a consensus target price of $4.75, indicating a … WebJun 25, 2024 · PolarityTE, Inc. is a regenerative tissue-based biotech company operating out of Salt Lake City, Utah, that has just started commercial operations with its primary SkinTE treatment product, aiming ...
WebRyan currently serves as the Chief Medical Officer of PolarityTE. Back to Management Team. Contact Info. PolarityTE Headquarters: 1960 South 4250 West Salt Lake City, UT 84104. Corporate Main: 800-560-3983 Investor Relations: 385-831-5284 Public Relations: 800-656-6194 Clinical Research: 800-653-8031. More Contact Info . WebApr 13, 2024 · PolarityTE currently has a consensus target price of $1.00, indicating a potential upside of 163.99%. Vaxart has a consensus target price of $4.75, indicating a potential upside of 698.19%.
WebPolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and ... WebJun 26, 2024 · PolarityTE ( COOL) stock tumbled again Tuesday after losing more than a quarter of its value a day earlier when a short-seller called it a "fraud" based on allegations tied to its patent ...
WebPolarityTE 2,539 followers 1y Report this post Report Report. Back ...
WebMay 16, 2024 · SALT LAKE CITY, May 16, 2024 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today announced that the Company will effectuate a 1-for-25 reverse stock split of the Company's issued and outstanding common stock, which will be effective under … philip laney jolly worcesterWebAt PolarityTE, our research is designed to deepen our understanding of skin’s complex regenerative cellular biology and use this understanding to develop new therapies for treatment of the most complex wounds, in patients with limited treatment options. We … Press Releases - PolarityTE Management Team - PolarityTE SEC Filings - PolarityTE Contact - PolarityTE About - PolarityTE Board of Directors - PolarityTE At PolarityTE, our research is designed to deepen our understanding of skin’s … In The News - PolarityTE PolarityTE is a commercial-stage biotechnology and regenerative … philip laney \\u0026 jolly malvernWebPR Newswire. PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. truff white